Climb Bio (CLYM) Assets (2020 - 2026)
Climb Bio's Assets came in at $246.29 million for Q2 2026, up 28.0% from $192.39 million a year earlier and up 61.6% from the prior quarter.
Powered by 
Analysis
Climb Bio (CLYM) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Climb Bio's Assets was $167.74 million, down 22.8% from FY2024.
- Assets carries a five-year compound annual growth rate of 46.8% (FY2020 to FY2025).
- Going back by year, Assets was $217.19 million in FY2024 (+96.6%), $110.47 million in FY2023 (-18.2%), $134.99 million in FY2022 (-22.1%) and $173.24 million in FY2021 (+603.3%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2020.
- Year-over-year, Assets increased in four of the last eight quarters, with growth averaging 28.2%.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 603.3%), and the weakest in Q1 2023 (a decline of 24.8%).
- Business Quant data shows CLYM's Assets at $152.37 million (Q1 2026), $167.74 million (Q4 2025) and $182.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Climb Bio | 894.05 Mn | 894.05 Mn | - | 246.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 246.29 Mn |
| Mar 31, 2026 | 152.37 Mn |
| Dec 31, 2025 | 167.74 Mn |
| Sep 30, 2025 | 182.30 Mn |
| Jun 30, 2025 | 192.39 Mn |
| Mar 31, 2025 | 200.74 Mn |
| Dec 31, 2024 | 217.19 Mn |
| Sep 30, 2024 | 222.20 Mn |
| Jun 30, 2024 | 226.02 Mn |
| Mar 31, 2024 | 109.33 Mn |
| Dec 31, 2023 | 110.47 Mn |
| Sep 30, 2023 | 112.74 Mn |
| Jun 30, 2023 | 116.27 Mn |
| Mar 31, 2023 | 122.09 Mn |
| Dec 31, 2022 | 134.99 Mn |
| Sep 30, 2022 | 140.86 Mn |
| Jun 30, 2022 | 150.11 Mn |
| Mar 31, 2022 | 162.42 Mn |
| Dec 31, 2021 | 173.24 Mn |
| Sep 30, 2021 | 182.25 Mn |
API Access
Climb Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CLYM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CLYM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CLYM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();